Cytochrome P4507B1 7α α α α-hydroxylates dehydroepiandrosterone (DHEA), epiandrosterone (EpiA) and 5α α α α-androstane-3β β β β,17β β β β-diol (Adiol). 11β β β β-Hydroxysteroid dehydrogenase type 1 (11β β β β-HSD1) interconverts 7α α α α-and 7β β β β-forms. Whether the interconversion proceeds through oxido-reductive steps or epimerase activity is investigated. 
INTRODUCTION
The 7α-hydroxylation of circulating dehydroepiandrosterone (DHEA), epiandrosterone (EpiA) and 5α-androstane-3β,17β-diol (Adiol) is catalyzed in animals and humans by the cytochrome P450 7B1 (CYP7B1) 1, 2, 3 . Thus, the 7α-hydroxylated derivatives of these steroids are found in human blood and urines 4, 5 . Circulating 7α-hydroxy-DHEA is accompanied by almost equivalent quantities of 7β-hydroxy-DHEA 6, 7 . Origin of 7β-hydroxy-DHEA and 7β-hydroxy-EpiA was investigated in several human models 8, 9 . Use of a yeast-expressed recombinant human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) helped to demonstrate that 7β-hydroxy-DHEA derived from 7α-hydroxy-DHEA through a 7-oxo-DHEA intermediate 10, 11 ( Fig. 1) . Thus, the human 11β-HSD1 catalyzed the interconversion of 7α-and 7β-hydroxy-DHEA through its oxido-reductive activity on 7-hydroxylated DHEA substrates. Whether this occurred with the 7-hydroxylated derivatives of EpiA and Adiol was also investigated. Indeed inter-conversion of the 7α-and 7β-hydroxysteroids was obtained by use of human tissue preparations 8, 9 and recombinant human 11β-HSD1 12, 13 . Nevertheless, no production of a putative 7-oxo intermediate could be detected and it was hypothesized that the human 11β-HSD1 would act as an epimerase on the 7α-and 7β-hydroxylated derivatives of EpiA and Adiol. In contrast, when either 7-oxo-EpiA 12 or 7-oxo-Adiol 13 were used as substrates for the 11β-HSD1 in the presence of NADPH, reduction into 7α-and 7β-hydroxy derivatives was obtained ( Fig. 1) .
In this work, our aims were to assess the 11β-HSD1-mediated interconversion of 7α-hydroxy-EpiA and 7α-hydroxy-Adiol into their respective 7β-hydroxylated derivatives, and to ascertain whether traces of 7-oxo intermediaries were produced. To these ends, we used the recombinant human 11β-HSD1 and radio-labelled steroid substrates through experiments where the non radioactive 7-oxo-steroids were used as traps for their putative production by the enzyme. In order to asses the mechanism taking place at the 11β-HSD1 active site, models of each 7-oxygenated steroid were computed and docked in the available crystal structure of human 11β-HSD1. This led to mechanistic assessment of the epimerisation mechanism. Table 1) . This proves that our experimental approach assesses the NADP + -dependent oxidation of 7β-hydroxy-DHEA to 7-oxo-DHEA catalyzed by the recombinant human 11β-HSD1, and that NADPH is not generated in sufficient quantities from NADP + for catalysis of 7α-hydroxy-DHEA production. In contrast, no radioactivity deriving from the [ 3 H]-5α-reduced substrates was detected in 7-oxo-EpiA and 7-oxo-Adiol traps ( Consideration of steroids bearing oxygen at the C 7 positions and comparison relative to cortisol and cortisone lead to the following: the steroid may be positioned as cortisol or either flipped or turned (Fig. 2) . The 7-oxo groups of all flipped or turned 7-oxosteroids could match correctly with the 11-oxo group of cortisone. In 7α-hydroxysteroids, the axial 7α-position could possibly match with the axial 11β-hydroxyl of cortisol only after a flip of the molecule.
RESULTS

Incubation of [
This was not the case with the equatorial 7β-position which stood opposite to the axial 11β-hydroxyl when either flipped or flipped and turned. The turned molecule would be the only structure bringing the 7β-hydroxyl into the vicinity of the 11β-hydroxyl. It was also noticed that the formulae of ∆ 5 steroids did not superpose exactly with those of 5α-reduced steroids.
These comparisons led us to examine the fitting of each steroid relative to Tyr 183 and Ser 170 in the active site of the cofactor-supplemented enzyme. Cortisone positioned in the NADPHfortified 11β-HSD1 active site proximal to the cofactor and to Tyr 183 with minimum energy required ( Table 2) . No other cortisone position would dock properly within the site. This positioning results in cortisol production from cortisone reduction (Fig. 3) . Once either turned or flipped, all 7-oxo-steroids were positioned in the site with the 7-oxo proximal to NADPH and to Tyr 183 . Nevertheless, the distance between 7-oxo and Tyr 183 was larger in 7-oxo-EpiA and 7-oxo-Adiol than in cortisone and 7-oxo-DHEA ( Table 2 ). This structure-related displacement brought the Ser 170 closer to the 7-oxo group. Thus NADPH-dependent reduction occurred on either turned or flipped 7-oxo-steroids, and led to the production of 7β-and 7α-reduced derivatives, respectively (Fig. 4) . This positioning structural approach permits assessment of the events taking place in the active site. It indicates that production of 7α-and 7β-reduced forms may result from two different docking positions of the 7-oxo-steroid substrates in the active site. In contrast, with 5α-reduced 7α-hydroxysteroids, the turned structures met with minimum energy requirements and the 7α-hydroxyl was positioned closer to Ser 170 than Tyr 183 ( Table 2) . With 5α-reduced 7β-hydroxysteroids, the flipped formulae met with minimum energy requirements and the 7β-hydroxyl positioned was in close vicinity to Ser 170 while Tyr 183 became more distal ( Table 2 
Incubation of 7-oxygenated steroids in H 2 18 O-reconstituted medium
We lyophilized 1 mg portions of the recombinant 11β-HSD1 in the presence of either NADP + or NADPH, and tested their activity before carrying out incubations in the presence of H 2 18 O.
As expected, no 18 O enrichment was detected in 7α-hydroxy-DHEA or 7β-hydroxy-DHEA after incubation of 7-oxo-DHEA in the presence of NADPH. Both 7α-hydroxy-DHEA and 7β-hydroxy-DHEA were oxidized into 7-oxo-DHEA in NADP + -fortified incubations without 18 O incorporation. As expected from the mechanism proposed above, the reduction of 7-oxoEpiA by NADPH produced both 7α-hydroxy-EpiA and 7β-hydroxy-EpiA containing no 18 O.
In the presence of NADP + as well as NADPH, 7α-hydroxy-EpiA and 7α-hydroxy-Adiol were converted to 7β-hydroxy-EpiA and 7β-hydroxy-Adiol containing no 18 O ( Table 3) . The 18 Ocontent of 7α-hydroxy-EpiA obtained from 7β-hydroxy-EpiA could not be measured due to the very low transformation yields. Thus, the 11β-HSD1 converts 7-oxo-steroids into both 7α-and 7β-epimers through a NADP(H)-dependent process which does not involve H 2 O from the medium.
DISCUSSION
We have already shown that the recombinant human 11β-HSD1 is an active NADP(H)-dependent oxido-reductase interconverting cortisol and cortisone in addition to 7-oxo-DHEA and 7α-hydroxy-DHEA and 7β-hydroxy-DHEA 10 . This finding was extended to the native enzyme present in human skin tissue homogenates 11 . In the presence of NADPH, the recombinant human 11β-HSD1 reduced 7-oxo-DHEA into 7β-hydroxy-DHEA in preference to 7α-hydroxy-DHEA as indicated by a higher V max /K M ratio ( Table 2) 10 . This preference for the 7β epimer was maintained in the NADP + -dependent oxidation of 7β-hydroxy-DHEA and 7α-hydroxy-DHEA. Other assays with 7α-and 7β-hydroxylated derivatives of EpiA 12 and Adiol 13 gave results conflicting with those obtained with DHEA derivatives. Thus, the NADPH-dependent 7α-reduction of 7-oxo-epiA and 7-oxo-Adiol was preferred over the 7β-reduction by the enzyme through V max /K M values as shown in Table 2 . In contrast to DHEA, the NADP + -dependent oxidation of 7α-and 7β-hydroxy-EpiA and 7α-and 7β-hydroxy-Adiol did not result in 7-oxo derivative productions. Instead, inter-conversion of the 7α-and 7β-hydroxylated forms was observed, with a preference for the production of the 7β-hydroxylated epimers 12, 13 . From these findings on 5α-reduced steroids, the mechanism driven by the recombinant human 11β-HSD1 remained open. Did the interconversion proceed through oxido-reductive steps or through a direct epimeric transformation? Oxido-reduction should process through ketone formation. Our previous kinetic studies indicated through apparent K M s and V max determinations that the conversion of 7α-into 7β-derivatives was preferred, as well as the reduction of 7-oxo into 7α-derivatives. On this basis, and because a very rapid oxido-reduction process could deplete the medium of a putative No label was found in the two 7-oxo-steroid traps, but small amounts of the radioactivity occurred at the level of 7α-hydroxylated derivatives. These formations did not occur in the absence of cofactor and were more dependent on NADPH than NADP + . Two conclusions may be drawn from these findings. First, the recombinant human 11β-HSD1 does not carry out the NADP + -dependent oxidation of 7β-hydroxy-EpiA and 7β-hydroxy-Adiol to 7-oxo-EpiA. Second, the enzyme carries out epimerisation of the 5α-reduced 7β-hydroxysteroids independently of the cofactor oxidation state. Nevertheless, presence of the cofactor was necessary for such epimerisation. It should be noted that the NADPH dependent reduction of 7-oxo-EpiA and 7-oxo-Adiol was described with a preferred production of the 7α-hydroxylated derivatives 12, 13 . It should also be noted that these findings obtained with the recombinant human 11β-HSD1 correlated well with other works using the native enzyme in human liver and intestinal preparations 8, 9 . Interpretation of the present findings deserved assessment through close examination and comparison of the steroid structures relative to the enzyme activity. Cortisone and all 7-oxo steroids are substrates for the NADPH-dependent reduction by the recombinant 11β-HSD1. One may expect for the 11-oxo and 7-oxo groups an equivalent positioning proximal to NADPH within the enzyme active site. Indeed, either a flip or a turn of the 7-oxo-steroid structure does align the 7 and 11 sp 2 carbons of 7-oxo steroids and cortisone, respectively, as previously suggested 14, 13 and as shown in and their fitting into the 11β-HSD1 active site could be assessed. Thus, flipped formulae of 7-oxo and 7β-hydroxysteroids were docked in the site, while turned formulae of 7-oxo-steroids and 7α-hydroxysteroids docked as well in the site (Fig. 3, Fig. 4 ). When applied to 7-oxosteroids, these two docking forms leads to the mechanism depicted in Fig. 4 where 7-oxosteroids are reduced in the α or β position when docked in a turned or flipped position, respectively. This proposal is made attractive by the explanation it may provide for the stereospecific reduction of 7-oxo-cholesterol to 7β-hydroxy-cholesterol, exclusively 15, 16, 17 .
Our model make it apparent that due to its large side chain, 7-oxo-cholesterol docking into the 11β-HSD1 active site may occur in the flipped position only, thereby leading to its reduction to 7β-hydroxy-cholesterol only.
Tyr 183 is located proximal to the bound cofactor within the human 11β-HSD1 active site and is responsible for the reducing activity 18, 19 . This is shown in Fig. 4 and ) provided mg quantities of chemically pure 7α-hydroxy-DHEA, 7α-hydroxy-EpiA, 7β-hydroxy-DHEA, 7β-hydroxyEpiA and 7-oxo-DHEA-17-ethylene-ketal. The latter steroid was reduced with hydrogen gas in the presence of Pd into 3β-hydroxy-5α-androstane-17-ethylene-ketal. After HCl treatment, the 3β-hydroxy-5α-androstane-7,17-dione (7-oxo-EpiA) was obtained. Both 7α-hydroxyAdiol and 7β-hydroxy-Adiol were obtained after NaBH 4 (Sigma-Aldrich) reduction of 7α-hydroxy-EpiA and 7β-hydroxy-EpiA, respectively. The produced steroids were all purified by preparative HPLC and their identity and purity were assessed after GC/MS with evidence for a single peak containing the relevant molecular ion. [ Steroid structure studies. The density functional theory within the Khon-Sham methodology 21 was used to model cortisol, cortisone and the 7-oxygenated steroids. The generalized gradient approximation was employed within Perdew-Burke-Ernzerhof exchangecorrelation functional formulation 22 . Calculations were performed with use of the ADF06 program package 23, 24 . The basis set was of triple-zeta quality + polarization with small frozen cores. Finally, the integration grid parameter, setting the numerical integration accuracy, was fixed to 5 (supplementary mol.2 data).
The recombinant human 11β β β β-HSD1. The recombinant human 11β-HSD1 was obtained in microsomes of the Sacharomyces cervisiae strain W303-1B (Mata; leu2-3 ) transformed with the V60-HSD1 construct as previously described 10 .
Bioinformatic analysis. The crystal structure of the human 11β-HSD1 with NADP was retrieved from the Protein Data Bank 25 (PDB code 1ILT). All heteroatoms were removed from the file and hydrogen atoms were added using the QuacPac program from Openeye Scientific Software. The docking experiments of the different steroids were performed using the flexible docking program Surflex 26 . The binding site for docking experiments was defined around the co-crystallized Adamantane Sulfone inhibitor. The 10 top scoring poses after docking were visually inspected in order to propose a binding mode for each compound. Selected images were generated by PyMol software.
Incubation protocols. Two different protocols were used, one for incubation with radiolabeled steroids, the second for incubation in 97% H 2 18 O. i) Each 7β-hydroxysteroid (0.5 µmol) spiked with 20,000 dpm of the relevant [ 3 H]-steroid was mixed with 0.5 µmol of the relevant 7-oxo-steroid and dried under vacuum at the bottom of 10 mL glass tubes prior to addition of 66.7 mM K 2 HPO 4 /KH 2 PO 4 buffer (pH 7.4) containing 1 mM EDTA. The mixture was pre-incubated at 28°C for 5 min. The cofactor (either 1 µM NADP+ or NADPH in 500 µL buffer) was added to the steroid substrates. Incubations commenced at the addition of a suspension of yeast microsomes containing the 11β-HSD1 (63.8 µL, 1 mg protein) and addition of buffer to the 1 mL mark. The process continued in a shaking water bath at 28°C for 30 min. ii) Tubes containing aliquot portions of the buffered enzyme suspension (1 mL, 1 mg protein) were added with either NADP+ or NADPH and lyophilized. In order to avoid the putative reinsertion of environmental water, a H 2
18
O spray was produced at the moment of vacuum breaking. The medium was reconstituted with 1 mL H 2 18 O and the mixture was preincubated at 28°C for 5 min. Incubation commenced at the addition of the steroid substrate in 10µL ethanol. The process continued in a shaking water bath at 28°C for 30 min. All incubations ceased at the addition of 0.5 mL acetone followed by 2 mL ethyl acetate. Extraction of the steroids was carried out with 2 mL ethyl acetate and was repeated three times.
Steroid separation and analysis. The radio-steroids extracted were analyzed by TLC. The separation of 7α-hydroxy-DHEA (R f 0.25) from 7β-hydroxy-DHEA (R f 0.38) and 7-oxo-DHEA (R f 0.55) on silica 60-coated glass plates (Merck, Darmstadt, Germany) required one development in ethyl acetate. Aluminium oxide-coated polyester plates from Machery-Nagel were developed twice in ethyl acetate for the separation of 7α-hydroxy-EpiA (R f 0.47) from 7β-hydroxy-EpiA (R f 0.55) and 7-oxo-EpiA (R f 0.79). The same system and plates were used for the separation of 7α-hydroxy-Adiol (R f 0.35) from 7β-hydroxy-Adiol (R f 0.47) and 7-oxoAdiol (R f 0.55). The steroid containing zones were scrapped off the plate and counted. The counting of each sample was carried out for 30 min in order to accumulate sufficient counts for precise dpm measurements. Steroids recovered after incubations in the presence of H 2 18 O were transformed into TMS derivatives and analyzed by GC/MS as previously reported 8 . 10, 12, 13 . Distances between the oxygen borne at the steroid 7-position and Tyr 183 , Ser 170 hydroxyl groups and active hydrogen-bearing C 4 of nicotinamide (NA) in NADPH are given. The distances in brackets are those measured in each product deriving from the reduction process. Each steroid model was positioned and docked at minimum energy settings into the computerized crystal structure of the human 11β-HSD1. Distances were obtained through use of PyMol software. 2 18 O prior to incubation with selected 7-oxygenated steroids. Substrates and metabolites were recovered, transformed into TMS derivatives and separated and analyzed by gas chromatography-mass spectrometry (GLC/MS). 18 O content of metabolites (M+2) was measured in M + and M + -15 ions after comparison with M+2 levels in the same ions from authentic standards. * Conversion rate too low for measurement.
Conversion
Yield (%) of metabolite 18 (orange) and nicotinamide from NADP(H) (black) at minimum energy settings. Steroid backbone, oxygen and hydrogen are depicted in blue, red and white, respectively. 7oxo-and 7-hydroxysteroids fitted proximal to the cofactor and Tyr 183 and Ser 170 after either a turn or a flip of their structures relative to cortisone and cortisol, respectively. In this tabular figure the flip for 7-oxo-steroids and 7β-hydroxysteroids and the turn of 7α-hydroxysteroids exemplified in Fig. 2 were selected, respectively.
Figure 4
Proposed mechanism generating both 7α-and 7β-hydroxysteroids after 11β-HSD1-catalyzed NADPH-dependent reduction of 7-oxo-steroid precursors. The crystal structure of the human 11β-HSD1 retrieved from the Protein Data Bank (PDB code 1ILT) was used with QuacPac program from Openeye Scientific Software. Docking of the different steroids was performed using the flexible docking program Surflex. The steroid substrates (blue) and products were docked in the site relative to Tyr 183 , Ser 170 (orange) and nicotinamide from NADP(H) (black) at minimum energy settings for each flipped or turned structure. Enzymatic reduction of turned structures results in 7α-hydroxylated product while flipped structures result in 7β-hydroxylated products.
Figure 5
Hypotheses for 11β-HSD1-catalyzed epimerisation of 5α-reduced 7-hydroxysteroids. The steroid depicted is 7α-hydroxy-EpiA docked in the enzyme site with the 7α-hydroxyl proximal to Ser 170 and distal to Tyr 183 . The first hypothesis involves one molecule of H 2 O which provides the -OH necessary for epimerisation to proceed through ketone-hydrate formation and a 7-ketone intermediate. Absence of 18 O enrichment after use of H 2 18 O eliminated such hypothesis. The second hypothesis implies reaction of Ser 170 for hemiketal production prior to reduction. This model applies as well to 7α-hydroxy-Adiol and 7β-hydroxy-Adiol. Once produced, the 7β-hydroxy of 7β-hydroxy-EpiA becomes distal to Ser 170 and this may justify the difficulty for the back reaction to proceed. 
